ICU (SeaStar Medical Holding) Tariff Resilience Score: 5/10 (As of Jul. 03, 2026)


ICU SeaStar Medical Holding Corp ICU
32 GF Score
Price $4.92
! 4 Warning Signs
View Full Analysis

What is SeaStar Medical Holding Tariff Resilience Score?

SeaStar Medical Holding ICU +0.92% 32 Tariff Resilience Score is 5 as of Jul. 03, 2026. GuruFocus rates ICU with a GF Score™ of 32/100. The stock has 4 warning signs investors should review. Among 1,373 Biotechnology companies, SeaStar Medical Holding ranks better than 62.27% on this metric.

SeaStar Medical Holding has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

SeaStar Medical Holding has SeaStar Medical Holding Corp faces moderate tariff exposure due to its reliance on imported medical components. While it has some pricing power, the specialized nature of its products limits supplier flexibility. Past tariffs have had a mixed impact on costs.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes SeaStar Medical Holding might have Average Resilient.

SeaStar Medical Holding  (NAS:ICU) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

SeaStar Medical Holding Tariff Resilience Score Related Terms

ICU vs TRAW, CALC, INAB: Tariff Resilience Score Comparison

For the Biotechnology subindustry, SeaStar Medical Holding's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SeaStar Medical Holding Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SeaStar Medical Holding's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where SeaStar Medical Holding's Tariff Resilience Score falls into.


ICU
32GF Score
SeaStar Medical Holding Corp ICU
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
SeaStar Medical Holding (ICU) has a Tariff Resilience Score of 5 as of Jul. 03, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, SeaStar Medical Holding ranks #518 out of 1373 companies in the Biotechnology industry, placing it in the top 37.7%.
Is SeaStar Medical Holding's Tariff Resilience Score too high?
SeaStar Medical Holding's current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. SeaStar Medical Holding's value of 5 is 25% above this industry median. Based on the distribution chart, SeaStar Medical Holding ranks #518 out of 1373 companies in the Biotechnology industry, which is above the industry midpoint. Overall, SeaStar Medical Holding has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does SeaStar Medical Holding's Tariff Resilience Score compare to TRAW and CALC?
According to the Biotechnology industry distribution chart, SeaStar Medical Holding ranks #518 out of 1373 companies for Tariff Resilience Score. This puts SeaStar Medical Holding in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. SeaStar Medical Holding's value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,373 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SeaStar Medical Holding's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SeaStar Medical Holding's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SeaStar Medical Holding stock overvalued right now?
SeaStar Medical Holding (ICU) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. SeaStar Medical Holding's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For SeaStar Medical Holding (ICU), the current Tariff Resilience Score is 5 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SeaStar Medical Holding Business Description

Address 3513 Brighton Boulevard, Suite 410, Denver, CO, USA, 80216
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
32GF Score

Get the complete analysis for ICU

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.92
Price